Playback speed
10 seconds
New Frontline Regimens in Peripheral T-Cell Lymphoma: Brentuximab Vedotin+CHP, Lenalidomide, Alemtuzumab and Romidepsin for CHOP/CHOP-like + Disease
178 views
October 18, 2019
Login to view comments.
Click here to Login